Conexeu Sciences Inc.
corporate_fare Company Profile
Conexeu Sciences Inc. (NASDAQ:CNXU) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for CNXU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for CNXU spans S-1, 8-K, 10-Q, 424B3.
Recent high-impact activity:
- Conexeu Registers 7.73M Shares for Resale; Up to $14.3M Warrant Proceeds Possible
- Conexeu Offers 1-for-1 Inducement Warrants to Pull Forward $2.30 Warrants
- Conexeu Details $5M Private Placement: 1.33M Units at $3.00, Insider $250K Escrowed for Vote
- $5M Private Placement Led by CEO and Insiders Funds Path to Q1 2027 FDA Filing
- Conexeu Sciences Q3 Loss Widens to $7.7M; Cash Runway Shrinks, Going Concern Warning Reiterated
Short Interest & Short Volume
1.12 days to coverFINRA reported short interest of 429,836 shares in CNXU as of the October 30, 2026 settlement, a 44.6% increase from the prior period — about 1.1 days to cover at its recent average daily volume. On November 20, 2026, 66.0% of CNXU volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
High riskFiling-implied dilution signals for CNXU, detected from its recent SEC filings · based on capital-structure filings through 2026-10-29.
Highly Dilutive Offering · Going Concern Warning
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →